Erlotinib

Results: 189



#Item
41

PDF Document

Add to Reading List

Source URL: www.precisiontherapeutics.com

Language: English - Date: 2014-06-25 01:38:57
42Microsoft Word - 14A002-TAR-WPI.doc

Microsoft Word - 14A002-TAR-WPI.doc

Add to Reading List

Source URL: www.astellas.us

Language: English - Date: 2015-05-01 11:57:22
43osi_pharmaceuticals_logo_cv

osi_pharmaceuticals_logo_cv

Add to Reading List

Source URL: www.fda.gov

Language: English
44BestReporter  The future of cancer, as told through the story of Renee Explaining in everyday language how the science that brought us the Human Genome Project is giving hope to cancer patients of today and tomorrow is n

BestReporter The future of cancer, as told through the story of Renee Explaining in everyday language how the science that brought us the Human Genome Project is giving hope to cancer patients of today and tomorrow is n

Add to Reading List

Source URL: www.cancerworld.org

Language: English - Date: 2013-10-18 09:06:50
45Roche at a Glance An Introduction to our Company February 2013  Basic facts at a glance

Roche at a Glance An Introduction to our Company February 2013 Basic facts at a glance

Add to Reading List

Source URL: www.institutmauricerapin.org

Language: English - Date: 2013-02-25 12:25:17
46QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest

QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest

Add to Reading List

Source URL: www.biologydirect.com

Language: English
47September 21, 2012  Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedica

September 21, 2012 Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedica

Add to Reading List

Source URL: astx.com

Language: English
48October 24, 2012  Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer DUBLIN, Calif., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceu

October 24, 2012 Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer DUBLIN, Calif., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceu

Add to Reading List

Source URL: astx.com

Language: English
49July 22, 2013  Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models Data Presented at 8th Wor

July 22, 2013 Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models Data Presented at 8th Wor

Add to Reading List

Source URL: astx.com

Language: English
50DECISION AID DATA SET – Third Line  Thank you for accepting the Decision Aid Upgrade challenge. Your task is to design a presentation of the data and statistics about treatment for late-stage lung cancer to promote sha

DECISION AID DATA SET – Third Line Thank you for accepting the Decision Aid Upgrade challenge. Your task is to design a presentation of the data and statistics about treatment for late-stage lung cancer to promote sha

Add to Reading List

Source URL: www.health2con.com

Language: English - Date: 2015-03-31 11:48:14